NCT06176820View on ClinicalTrials.gov

Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
Menopause Related ConditionsAtrophic VaginitisGenitourinary Syndrome of MenopauseSexual Dysfunction
Interventions
DRUG

Vaginal Gel

Arm 1 will apply 2.5 gram of VHAL gel intravaginally using vaginal applicator 2 times per week for 3 months

DRUG

Vaginal lubricant

Arm 2 will apply 2.5 gram of vaginal lubricant intravaginally using vaginal applicator 2 times per week for 3 months

All Listed Sponsors
lead

Sarawak General Hospital

OTHER

NCT06176820 - Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause | Biotech Hunter | Biotech Hunter